Rare cervical cancer under the microscope: new study aims to unlock its secrets
NCT ID NCT07240753
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study focuses on a rare and aggressive type of cervical cancer called large cell neuroendocrine carcinoma (LCNEC). Researchers will look back at medical records and follow 200 patients over time to understand the disease's behavior and what factors affect survival. The goal is to improve diagnosis and help doctors make better treatment decisions for this challenging cancer.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for LARGE CELL NEUROENDOCRINE CARCINOMA OF THE CERVIX are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- One drop, many cancers? a rapid test aims to spot cancer signals in blood, urine, or saliva
- Particle beam and immune therapy join forces against cervical cancer
- Dual immunotherapy plus chemo may shrink cervical tumors before surgery
- Can a simple WhatsApp message save lives? chile tests new screening nudge
- New hope for hard-to-treat cancers? experimental combo enters phase 2 trial
- New hope for rare ovarian cancer: immunotherapy combo tested in phase II trial